Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SORAFENIB TABLETS safely and effectively. See full prescribing information for SORAFENIB TABLETS. SORAFENIB tablets, for oral use Initial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
Sorafenib tablets are indicated for the treatment of patients with unresectable hepatocellular carcinoma (HCC). Sorafenib tablets are indicated for the treatment of patients with advanced renal cell carcinoma (RCC). Sorafenib tablets are indicated for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.
- generic_name
- sorafenib
- product_names
- Sorafenib
- ndc
- 0480-5425, 0480-5425-89
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en